Agenus Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | Agenus Inc.

Agenus Inc. | Mutual Funds

Mutual Funds that own Agenus Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Total Stock Market Index Fund

2,457,912

2.17%

07/31/2018

iShares Russell 2000 ETF

1,693,940

1.5%

-906

0.01%

09/06/2018

Vanguard Extended Market Index Fund

1,126,675

07/31/2018

iShares Russell 2000 Growth ETF

854,549

0.75%

0.02%

09/06/2018

Fidelity Select Biotechnology Portfolio

650,018

0.56%

0.02%

07/31/2018

Fidelity Spartan Extended Market Index Fund

343,477

0.3%

07/31/2018

Schwab US Small Cap ETF

226,861

0.2%

0.01%

09/06/2018

iShares Micro Cap ETF

214,241

0.19%

0.04%

09/06/2018

Fidelity Advisor Biotechnology Fund

213,523

0.19%

0.02%

07/31/2018

203,849

0.18%

108,461

0.14%

08/10/2017

About Agenus

View Profile

Address	3 Forbes Road Lexington Massachusetts 02421 United States
Employees	-
Website	http://www.agenusbio.com
Updated	07/08/2019
Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes AGEN1884, Next-gen CTLA-A, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H.